Ajay Samkaria/LinkedIn
May 22, 2026, 13:36
Ajay Samkaria։ A Compatible Crossmatch Does Not Always Mean Complete Safety
Ajay Samkaria, Product and Application Manager India at Diagast, shared a post on LinkedIn:
“Crossmatch protects the present transfusion.
Antibody screening protects the patient’s future.
A compatible crossmatch does not always mean complete transfusion safety.
Some clinically significant antibodies may still go undetected unless proper antibody screening is performed.
That’s why modern transfusion medicine is shifting from: ‘minimum compatibility’ to ‘future transfusion safety.’
Think Beyond Crossmatch.
Think Antibody Screening.
Think Patient Safety.”
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator